TIANAN MEDICARE(00383.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 47.36 million, YoY increase of 295.37%

NewTimeSpace News: August 14, 2026, TIANAN MEDICARE(00383.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 827.1 million, increased by 5.61% YoY; Net Profit stood at HKD 52.78 million, YoY increase of 258.1%; Profit Attributable to Shareholders stood at HKD 47.36 million, YoY increase of 295.37%; Basic Earnings Per Share (EPS) stood at HK cents 4.42.

In terms of profitability, TIANAN MEDICARE Gross Profit changed from HKD 158.64 million in the same period last year to HKD 169.95 million in the current period, increased by HKD 11.31 million; gross profit margin changed from 20.26% in the same period last year to 20.55% in the current period, increased by 0.29 percentage points; net profit changed from HKD 14.74 million in the same period last year to HKD 52.78 million in the current period, increased by HKD 38.04 million; net profit margin changed from 1.88% in the same period last year to 6.38% in the current period, increased by 4.5 percentage points.

In terms of earnings quality, TIANAN MEDICARE Operating Profit changed from HKD 35.33 million in the same period last year to HKD 67.01 million in the current period, increased by HKD 31.68 million; Operating Profit Margin changed from 4.51% in the same period last year to 8.1% in the current period, increased by 3.59 percentage points.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.